News

Hyperfine Appoints New Board of Directors

Hyperfine Appoints New Board of Directors

(GUILFORD, CT – December 13, 2021) Hyperfine Inc., creator of Swoop®, the first FDA-cleared portable magnetic resonance imagingTM (MRI) device, today announced the Board of Directors that will serve subsequent to the closing of the previously announced business...

read more

Exploring the Potential of Low Field MR Imaging in Radiology

A Fireside Chat at RSNA 2020 Dr. Eliot Siegel (University of Maryland, VA Maryland Healthcare System) Joined Dr. Khan Siddiqui (Hyperfine Chief Medical Officer) for a Discussion on the Utility of Low Field MR Imaging and Clinical Workflow as part of RSNA 2020...

Hyperfine’s Portable MRI System Demonstrates High Accuracy for Detection of Brain Hemorrhage in Study Published in Nature Communications

First-of-its-Kind Swoop System Designed to Offer an Accessible, Affordable Option for Brain Imaging (GUILFORD, CT – August 25, 2021) Hyperfine Inc. today announced results of a study of the company’s FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop,™ published in Nature Communications. The study, which was conducted at Yale New Haven Hospital, demonstrated high accuracy for Swoop for the detection of hemorrhagic stroke.

read more

Hyperfine’s Portable MRI System Demonstrates High Accuracy for Detection of Brain Hemorrhage in Study Published in Nature Communications

First-of-its-Kind Swoop System Designed to Offer an Accessible, Affordable Option for Brain Imaging (GUILFORD, CT – August 25, 2021) Hyperfine Inc. today announced results of a study of the company’s FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop,™ published in Nature Communications. The study, which was conducted at Yale New Haven Hospital, demonstrated high accuracy for Swoop for the detection of hemorrhagic stroke.

Hyperfine’s Portable MRI System Demonstrates High Accuracy for Detection of Brain Hemorrhage in Study Published in Nature Communications

First-of-its-Kind Swoop System Designed to Offer an Accessible, Affordable Option for Brain Imaging (GUILFORD, CT – August 25, 2021) Hyperfine Inc. today announced results of a study of the company’s FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop,™ published in Nature Communications. The study, which was conducted at Yale New Haven Hospital, demonstrated high accuracy for Swoop for the detection of hemorrhagic stroke.

Hyperfine Appoints New Board of Directors

Hyperfine Appoints New Board of Directors

(GUILFORD, CT – December 13, 2021) Hyperfine Inc., creator of Swoop®, the first FDA-cleared portable magnetic resonance imagingTM (MRI) device, today announced the Board of Directors that will serve subsequent to the closing of the previously announced business...

read more

Awards & Recognition

Awards Image For Hyperfine from Frost and Sullivan

Best Practices Product Innovation Award from Frost & Sullivan

Fast Company Award for Hyperfine

Fast Company Magazine World Changing Ideas honorable mention in two categories: North America and Health

Award from Aunt Minnie - Image

Best New Radiology Vendor of 2020 from Aunt Minnie

incubat ED Awards Image for Hyperfine

MD+DI Gold Medical Design Excellence Award in the Radiology, Imaging, and Electromechanical Devices category

Image of award from CES for Hyperfine

2021 Innovation Awards Honoree from CES

Image of Fierce 15 Award for Hyperfine

Named by Fierce Medtech as one of 2020’s Fierce 15